These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 30971805)
21. White-Coat and Reverse White-Coat Effects Correlate with 24-h Pulse Pressure and Systolic Blood Pressure Variability in Children and Young Adults. Fujita H; Matsuoka S; Awazu M Pediatr Cardiol; 2016 Feb; 37(2):345-52. PubMed ID: 26481222 [TBL] [Abstract][Full Text] [Related]
22. Short-term variability and nocturnal decline in ambulatory blood pressure in normotension, white-coat hypertension, masked hypertension and sustained hypertension: a population-based study of older individuals in Spain. Gijón-Conde T; Graciani A; López-García E; Guallar-Castillón P; García-Esquinas E; Rodríguez-Artalejo F; Banegas JR Hypertens Res; 2017 Jun; 40(6):613-619. PubMed ID: 28179625 [TBL] [Abstract][Full Text] [Related]
23. Prognostic significance of masked and white-coat hypertension in the general population: the Finn-Home Study. Hänninen MR; Niiranen TJ; Puukka PJ; Johansson J; Jula AM J Hypertens; 2012 Apr; 30(4):705-12. PubMed ID: 22278146 [TBL] [Abstract][Full Text] [Related]
24. [Prognostic importance of white coat and masked hypertension]. Gustavsen P; Hansen TW Ugeskr Laeger; 2009 Jun; 171(24):2019-22. PubMed ID: 19523366 [TBL] [Abstract][Full Text] [Related]
25. Subclinical arterial and cardiac damage in white-coat and masked hypertension. Wojciechowska W; Stolarz-Skrzypek K; Olszanecka A; Klima Ł; Gąsowski J; Grodzicki T; Kawecka-Jaszcz K; Czarnecka D Blood Press; 2016 Aug; 25(4):249-56. PubMed ID: 26953075 [TBL] [Abstract][Full Text] [Related]
26. Office blood pressure is a predictor of aortic elastic properties and urinary protein excretion in subjects with white coat hypertension. Aznaouridis K; Vlachopoulos C; Masoura K; Pietri P; Vyssoulis G; Ioakeimidis N; Stefanadis C; Tousoulis D Int J Cardiol; 2016 Jan; 203():98-103. PubMed ID: 26498870 [TBL] [Abstract][Full Text] [Related]
27. Antihypertensive drug treatment in white-coat hypertension: data from the Plaque HYpertension Lipid-Lowering Italian Study. Mancia G; Facchetti R; Quarti-Trevano F; Grassi G J Hypertens; 2022 Oct; 40(10):1909-1917. PubMed ID: 35881420 [TBL] [Abstract][Full Text] [Related]
28. White-coat hypertension, as defined by ambulatory blood pressure monitoring, and subclinical cardiac organ damage: a meta-analysis. Cuspidi C; Rescaldani M; Tadic M; Sala C; Grassi G; Mancia G J Hypertens; 2015 Jan; 33(1):24-32. PubMed ID: 25380162 [TBL] [Abstract][Full Text] [Related]
29. Risk of new-onset metabolic syndrome associated with white-coat and masked hypertension: data from a general population. Cuspidi C; Facchetti R; Bombelli M; Sala C; Tadic M; Grassi G; Mancia G J Hypertens; 2018 Sep; 36(9):1833-1839. PubMed ID: 29965885 [TBL] [Abstract][Full Text] [Related]
30. Prognostic value of 24-hour blood pressure in pregnancy. Bellomo G; Narducci PL; Rondoni F; Pastorelli G; Stangoni G; Angeli G; Verdecchia P JAMA; 1999 Oct; 282(15):1447-52. PubMed ID: 10535435 [TBL] [Abstract][Full Text] [Related]
31. Short- and long-term risk of cardiovascular events in white-coat hypertension. Pierdomenico SD; Lapenna D; Di Mascio R; Cuccurullo F J Hum Hypertens; 2008 Jun; 22(6):408-14. PubMed ID: 18288127 [TBL] [Abstract][Full Text] [Related]
32. Development of preeclampsia in pregnant women with white-coat hypertension: a systematic review and meta-analysis. Hadizadeh S; Shahmohamadi E; Khezerlouy-Aghdam N; Heidary L; Tarafdari A; Hantoushzadeh S; Ayati A; Foroutani L; Ahmadi-Tafti H; Mohseni-Badalabadi R; Vahidi H; Hadizadeh A; Mousavi S Arch Gynecol Obstet; 2024 Mar; 309(3):929-937. PubMed ID: 37792010 [TBL] [Abstract][Full Text] [Related]
34. White coat hypertension is a cardiovascular risk factor: a 10-year follow-up study. Gustavsen PH; Høegholm A; Bang LE; Kristensen KS J Hum Hypertens; 2003 Dec; 17(12):811-7. PubMed ID: 14704724 [TBL] [Abstract][Full Text] [Related]
35. Cardiovascular prognosis of sustained and white-coat hypertension in patients with type 2 diabetes mellitus. Eguchi K; Hoshide S; Ishikawa J; Ishikawa S; Pickering TG; Gerin W; Ogedegbe G; Schwartz JE; Shimada K; Kario K Blood Press Monit; 2008 Feb; 13(1):15-20. PubMed ID: 18199919 [TBL] [Abstract][Full Text] [Related]
36. Cardiac and arterial target organ damage in adults with elevated ambulatory and normal office blood pressure. Liu JE; Roman MJ; Pini R; Schwartz JE; Pickering TG; Devereux RB Ann Intern Med; 1999 Oct; 131(8):564-72. PubMed ID: 10523216 [TBL] [Abstract][Full Text] [Related]
37. Long-Term Stroke Risk Due to Partial White-Coat or Masked Hypertension Based on Home and Ambulatory Blood Pressure Measurements: The Ohasama Study. Satoh M; Asayama K; Kikuya M; Inoue R; Metoki H; Hosaka M; Tsubota-Utsugi M; Obara T; Ishiguro A; Murakami K; Matsuda A; Yasui D; Murakami T; Mano N; Imai Y; Ohkubo T Hypertension; 2016 Jan; 67(1):48-55. PubMed ID: 26527046 [TBL] [Abstract][Full Text] [Related]
38. Effectiveness of olmesartan-based treatment on home and clinic blood pressure in elderly patients with masked and white coat hypertension. Kushiro T; Kario K; Saito I; Teramukai S; Mori Y; Okuda Y; Shimada K Hypertens Res; 2015 Mar; 38(3):178-85. PubMed ID: 25354777 [TBL] [Abstract][Full Text] [Related]
39. Possible cardiovascular risks of white coat hypertension: updated. Chrysant SG Postgrad Med; 2023 Jun; 135(5):466-471. PubMed ID: 37161879 [TBL] [Abstract][Full Text] [Related]
40. Ambulatory blood pressure measurement in the main cities of Cameroon: prevalence of masked and white coat hypertension, and influence of body mass index. Takah N; Dzudie A; Ndjebet J; Wawo G; Kamdem F; Monkam Y; Luma H; Ngu KB; Kengne AP Pan Afr Med J; 2014; 19():240. PubMed ID: 25848455 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]